The biotechnology company has used its drug delivery system DehydraTECH, to ensure that CBD enters the bloodstream within minutes
() (OTCMKTS:LXRP) said Thursday that it had launched ChrgD+, a water-soluble hemp oil, in a powdered format with the help of its drug delivery system DehydraTECH, which works by helping the body absorb compounds faster and more effectively.
In a statement, the Kelowna, British Columbia-based biotechnology company said the product was available for sale online in the US through chrgd.life
Lexaria Bioscience’s DehydraTECH drug-delivery platform, masks unwanted tastes, improves onset speed and increases the bioavailability of active pharmaceutical ingredients in a simple and cost-effective platform.
READ: Lexaria Bioscience secures cannabis R&D license from Health Canada
It allows drugs and vitamins — in the case of cannabis, CBD and THC — to enter the bloodstream faster than existing drug delivery platforms.
In addition to taking advantage of its DehydraTECH technology, the company said ChrgD+ also uses the “highest quality” multi-spectrum hemp oil ingredients.
In its statement, the company said ChrgD+ does not use CBD isolates that deprive consumers of the “synergistic benefits” of multi-spectrum oils. It also does not use artificial flavors or sweeteners to mask or cover-up the strong flavors associated with hemp oil. Instead it relies on the DehydraTECH technology to gently remove “unpleasant flavors.”
The company claims ChrgD+ acts fast: in various human and animal tests, Lexaria has repeatedly demonstrated its ability to deliver CBD into the bloodstream within 2-15 minutes.
Every packet of ChrgD+ has a manufacturing batch code. This allows customers to enter the code into the ChrgD+ website and pull up the actual tested lab results for the potency of the ingredients.
Contact Uttara Choudhury at [email protected]
Follow her on Twitter: @UttaraProactive
